Journal Menu
- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Chemotherapy Research and Practice
Volume 2011 (2011), Article ID 730360, 12 pages
doi:10.1155/2011/730360
Review Article
Role of HER2-Targeted Agents in Adjuvant Treatment for Breast Cancer
Department of Medical Oncology/Hematology, Cancer Center, Kobe University Hospital, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
Received 1 November 2010; Revised 4 March 2011; Accepted 16 June 2011
Academic Editor: J. B. Vermorken
Copyright © 2011 Toru Mukohara. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
How to Cite this Article
Toru Mukohara, “Role of HER2-Targeted Agents in Adjuvant Treatment for Breast Cancer,” Chemotherapy Research and Practice, vol. 2011, Article ID 730360, 12 pages, 2011. doi:10.1155/2011/730360